Mark Perrin
2014
In 2014, Mark Perrin earned a total compensation of $5.4M as Chief Executive Officer and Chairman of the Board at InVivo Therapeutics Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $140,000 |
|---|---|
| Option Awards | $4,628,496 |
| Salary | $392,308 |
| Stock Awards | $60,000 |
| Other | $161,557 |
| Total | $5,382,361 |
Perrin received $4.6M in option awards, accounting for 86% of the total pay in 2014.
Perrin also received $140K in non-equity incentive plan, $392.3K in salary, $60K in stock awards and $161.6K in other compensation.
Rankings
In 2014, Mark Perrin's compensation ranked 1,405th out of 13,032 executives tracked by ExecPay. In other words, Perrin earned more than 89.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,405 out of 13,032 | 89th |
Division Manufacturing | 506 out of 4,965 | 90th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 61 out of 731 | 92nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 30 out of 441 | 93rd |
Industry Surgical and Medical Instruments and Apparatus | 16 out of 270 | 94th |
Source: SEC filing on April 25, 2017.
Perrin's colleagues
We found four more compensation records of executives who worked with Mark Perrin at InVivo Therapeutics Holdings in 2014.